Thyroid Gland Adenocarcinoma — Trials

Thyroid Gland Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

195 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 43
Recruiting: 17
Ph III recruiting: 4
Growth YoY: —
Industry share: 7%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 25.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (13)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01417442	BRAF V600E Mutations In Papillary Thyroid Carcinoma	unknown	Early Phase 1	150	Bezmialem Vakif UniversityOTHER	1	Aug 16, 2011	clinicaltrials

Data updated 23 days agoSource updated Aug 16, 2011source: clinicaltrials